Completed PHASE1 INTERVENTIONAL 1-arm NCT01049880

A Research Trial of High Dose Vitamin C and Chemotherapy for Metastatic Pancreatic Cancer

A Phase I Trial of Ascorbic Acid and Gemcitabine for the Treatment of Metastatic Pancreatic Cancer

Sponsor: Holden Comprehensive Cancer Center

Interventions Gemcitabine with escalating ascorbic acid

Updated 6 times since 2017 Last updated: Apr 19, 2017 Started: Dec 31, 2009 Primary completion: Feb 28, 2013 Completion: Mar 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Pancreatic Neoplasms and is currently completed. Holden Comprehensive Cancer Center leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Holden Comprehensive Cancer Center
Joseph J. Cullen
University of Iowa

Data source: University of Iowa

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Iowa City, United States